Starten Sie Ihre Suche...


Wir weisen darauf hin, dass wir technisch notwendige Cookies verwenden. Weitere Informationen

Forschungszentrum für Immuntherapie (FZI)

Forschungsschwerpunkt / Johannes Gutenberg-Universität Mainz

Publikationen
Ergebnisse pro Seite:  10

Liu, Xingfeng; Huai, Jisen; Endle, Heiko et al.

PRG-1 Regulates Synaptic Plasticity via Intracellular PP2A/beta 1-Integrin Signaling

DEVELOPMENTAL CELL. Bd. 38. H. 3. 2016 S. 275-290


Karsdal, Morten A.; Henriksen, Kim; Nielsen, Mette J. et al.

Pro-C3, a novel serum marker of pure fibrogenesis, identifies patients with progressive liver fibrosis and responders to anti-fibrotic therapy

HEPATOLOGY. Bd. 63. H. 1 SUPP. 2016 S. 209A-210A


Plachter, Bodo

Prospects of a vaccine for the prevention of congenital cytomegalovirus disease

MEDICAL MICROBIOLOGY AND IMMUNOLOGY. Bd. 205. H. 6. 2016 S. 537-547


Wlodarczyk, Agnieszka; Holtman, Inge R.; Bruttger, Julia et al.

Protective roles for microglia in neuroinflammation

SCANDINAVIAN JOURNAL OF IMMUNOLOGY. Bd. 83. H. 5. 2016 S. 369-369


Wlodarczyk, A.; Holtman, I. R.; Bruttger, J. et al.

Protective roles for microglia in neuroinflammation

EUROPEAN JOURNAL OF IMMUNOLOGY. Bd. 46. 2016 S. 1042-1043


Ulges, Alexander; Witsch, Esther J.; Pramanik, Gautam et al.

Protein kinase CK2 governs the molecular decision between encephalitogenic T(H)17 cell and T-reg cell development

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. Bd. 113. H. 36. 2016 S. 10145-10150


Backes, Simone; Jaeger, Clemens; Dembek, Claudia J. et al.

Protein-prime/modified vaccinia virus Ankara vector-boost vaccination overcomes tolerance in high-antigenemic HBV-transgenic mice

VACCINE. Bd. 34. H. 7. 2016 S. 923-932


Schirmeister, Tanja; Kesselring, Jochen; Jung, Sascha et al.

Quantum Chemical-Based Protocol for the Rational Design of Covalent Inhibitors

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY. Bd. 138. H. 27. 2016 S. 8332-8335



Lemmermann, Niels A. W.; Reddehase, Matthias J.

Refining human T-cell immunotherapy of cytomegalovirus disease: a mouse model with 'humanized' antigen presentation as a new preclinical study tool

MEDICAL MICROBIOLOGY AND IMMUNOLOGY. Bd. 205. H. 6. 2016 S. 549-561